Biomaterial Database

[Effect of Prodectin on various blood clotting factors]. 1978

S Czaplicki, and B Ostrowska, and K Sułek

UI	MeSH Term	Description	Entries
D008055	Lipids	A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)	Lipid
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D011727	Pyridinolcarbamate	A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)	Pyricarbate,2,6-Pyridinedimethanol-bis-(N-methylcarbamate),Anginin,Angioxine,Colesterinex,Duaxol,Duvaline,Gasparol,Lisator,Movecil,P-23,Parmidine,Prodectin,Sospitan,P 23,P23
D001777	Blood Coagulation	The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.	Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002219	Carbamates	Derivatives of carbamic acid, H2NC(	Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D003327	Coronary Disease	An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.	Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

S Czaplicki, and B Ostrowska, and K Sułek

[Molecular-biology findings on various blood clotting factors].

January 1972, Folia haematologica (Leipzig, Germany : 1928),

S Czaplicki, and B Ostrowska, and K Sułek

Effect of blood soluble clotting factors on coagulation profile.

August 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,

S Czaplicki, and B Ostrowska, and K Sułek

The effect of surface on various clotting constituents of the blood.

January 1958, Bibliotheca haematologica,

S Czaplicki, and B Ostrowska, and K Sułek

PLASMA LEVELS OF VARIOUS BLOOD CLOTTING FACTORS IN GERMFREE RATS.

November 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),

S Czaplicki, and B Ostrowska, and K Sułek

[Effect of hirudin-thrombin and phenylmethylsulfonyl-thrombin on various blood clotting indices].

March 1981, Biulleten' eksperimental'noi biologii i meditsiny,

S Czaplicki, and B Ostrowska, and K Sułek

Report of the Subcommittee on New Clotting Factors. International Committee on Blood Clotting Factors.

January 1965, Thrombosis et diathesis haemorrhagica. Supplementum,